Tabunda, Lyqa Czyriel C.

HRN: 21-84-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/25/2022
08/31/2022
IV
440mg
Q8
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: